The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 31, 2017
Filed:
Jun. 10, 2016
Applicant:
Denali Therapeutics, Inc., South San Francisco, CA (US);
Inventors:
Raksha Acharya, Bedford, MA (US);
Duane A. Burnett, Wayland, MA (US);
Matthew Gregory Bursavich, Needham, MA (US);
Andrew Simon Cook, Stow, MA (US);
Bryce Alden Harrison, Framingham, MA (US);
Andrew J. McRiner, Melrose, MA (US);
Assignee:
DENALI THERAPEUTICS, INC., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); C07D 413/14 (2006.01); A61K 31/535 (2006.01); C07D 247/02 (2006.01); C07D 271/02 (2006.01); C07D 273/02 (2006.01); C07D 273/04 (2006.01); C07D 413/04 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 31/535 (2013.01); C07D 247/02 (2013.01); C07D 271/02 (2013.01); C07D 273/02 (2013.01); C07D 273/04 (2013.01); C07D 413/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract
The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.